Episode 64 What Impacts IA?
We reflect on our recent guests and dive into the realities of diet, movement, and why hospital appointments never seem to run smoothly
Episode 63 Mel Brooke: PSA & PRP-NeTT
Mel Brooke shares how living with psoriatic arthritis & fibromyalgia led her from symptom‑tracking and peer support into shaping national rheumatology research through PRPnett, proving just how powerful patient voices can be.
Episode 62 Jamie Boder: Yoga For AS
Jamie Boder joins us for a powerful, honest conversation about being diagnosed with Axial Spondyloarthritis (AxSpA) at 18, navigating Crohn’s disease, and learning to care for his whole self.
Episode 61 Why is IA so misunderstood?
This week’s episode brings back a long‑overdue Q&A, complete with a side of chaos.
Episode 60 Is it Brain Fog?
This week we dive into brain fog, research linking weather to symptom flares, and all the usual life chaos along the way. Plus the usual Inflammatory! humour.
Episode 59 EULAR 2026 Insights
Two weeks off didn’t happen – EULAR 2026 did. A fast, engaging recap of movement, mental health, youth in research, and the power of real patient voices.
Episode 58 What’s the Human side of IA?
“These are the things that people don’t tell you…”
We look at the everyday struggles of inflammatory arthritis, from washing your hair to simply getting through the day without pain.
Episode 57 Beyond Awareness Days
From biologic reviews lost in the system to the emotional load of chronic illness, this episode gets real about the everyday challenges of IA. Awareness days may come and go, but the lived experience is constant.
Episode 56 IA Insights with Dr Rosemary Hollick
Dr Rosemary Hollick joins us to unpack the realities of inflammatory arthritis, from symptoms to treatment breakthroughs ,and the power of patient voices in research.
Episode 55 British Society for Rheumatology 2026
Our first national conference at BSR Glasgow left us exhausted, inspired, and more connected than ever. Join us as we share the real behind‑the‑scenes of meeting clinicians, researchers, and the wider rheumatology community.
